Page last updated: 2024-10-25

dantrolene and Bone Loss, Osteoclastic

dantrolene has been researched along with Bone Loss, Osteoclastic in 2 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaji, H1
Sugimoto, T1
Kanatani, M1
Chihara, K1
Miyauchi, A1
Hruska, KA1
Greenfield, EM1
Duncan, R1
Alvarez, J1
Barattolo, R1
Colucci, S1
Zambonin-Zallone, A1
Teitelbaum, SL1
Teti, A1

Other Studies

2 other studies available for dantrolene and Bone Loss, Osteoclastic

ArticleYear
High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1996, Volume: 11, Issue:7

    Topics: Animals; Bone Resorption; Calcium; Calcium Channel Blockers; Cells, Cultured; Cellular Senescence; D

1996
Osteoclast cytosolic calcium, regulated by voltage-gated calcium channels and extracellular calcium, controls podosome assembly and bone resorption.
    The Journal of cell biology, 1990, Volume: 111, Issue:6 Pt 1

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e

1990